For families facing rare epilepsy, the search for a diagnosis can take years, but answers can bring direction and community.
Estimated reading time:4minutes
For people facing a rare disease, the journey to a diagnosis is long, isolating, and costly. Families encounter more barriers than pathways, and patients may see dozens of doctors and undergo countless tests before finally receiving a diagnosis. More than 25 million Americans face this diagnostic journey, and we must listen to them to deliver a system that brings answers.
Living at the edge of science
We are living in a time of remarkable progress in biomedical science, the result of a century of investment in understanding and improving human health. However, if you are living at the edge of scientific understanding, the promise of that progress seems out of reach. If you have a child experiencing seizures, every day and every episode without an answer feels like an eternity.
This undiagnosed community of patients and families has stories to share, lessons learned to benefit others, and biological clues that can improve understanding of epilepsy and speed diagnosis for others. We spoke with Kelley Coleman, mom to 13-year-old Aaron, and Jessica Swanson, mom to daughter Isla, to share the barriers and hope experienced firsthand on their path to answers.
The path to diagnosis
When asked about their family’s experience, Swanson described, “Our daughter, Isla, began having seizures when she was just 7 months old. From that moment, our lives became a search for answers. Like so many families with a child who has a rare disease, we entered a world we knew nothing about — specialists, testing, therapies, medications, hospital visits, and a tremendous amount of uncertainty.
“The hardest part of being undiagnosed was not knowing what the future might look like for our daughter or whether we were making the right decisions for her. Getting a diagnosis was not a single test or a single moment; it took years. It wasn’t until Isla was accepted into the Undiagnosed Diseases Network (UDN) and underwent whole exome sequencing that we finally received the correct diagnosis: CDKL5 deficiency disorder, a rare genetic disorder associated with early-onset seizures and significant neurological and developmental challenges.”
Coleman shared, “Aaron began his genetic testing odyssey at 3 months old. When your baby starts accumulating subdiagnoses related to an unknown genetic syndrome, it’s as scary as you’re imagining. Epilepsy, failure to thrive, autism, cortical vision impairment, feeding tube, global delays, and more. We spent years taking Aaron to specialists and therapies, learning about disability, and restructuring our lives to accommodate his caregiving needs. When we met with our UDN geneticist at UCLA 12 years into the diagnostic odyssey and eight years after initial examination by the UDN, we never expected Dr. Martinez to walk in and say, ‘We have a diagnosis.’”
The impact of a diagnosis
“Finally, at the age of 12, Aaron would have a community of others on this journey with him,” Coleman said. “I didn’t realize just how much I needed answers until we received the diagnosis. A diagnosis gives families answers and community, but also access to medical specialists, insurance coverage, social services, and more.”
Similarly, Swanson shared, “Receiving that diagnosis was difficult, but it was also incredibly important. After years of searching, we finally had a direction. We could connect with specialists who understood CDKL5, find other families walking the same road, and make decisions based on her specific disorder rather than continuing to treat each symptom as an isolated problem.”
Delivering answers for more families
When asked about what would be most helpful to other families on this journey, both families agreed: a clearer roadmap from the very beginning and a community of people who understand.
Swanson added, “When a child begins showing signs of a rare neurological disorder, parents shouldn’t have to become experts in genetics, insurance, clinical trials, specialty care, therapies, education, and disability services simply to figure out what to do next. I would love to see earlier and easier access to genetic testing, better coordination between specialists, clearer information about available research and clinical trials, and stronger systems for connecting newly diagnosed families with organizations and other families who understand their condition.”
Coleman talked about the importance of belonging: “The Undiagnosed Diseases Network Foundation community has been an important connection to others with similar journeys. You don’t realize just how much you need that community until you’ve found it.”
Ending the diagnostic odyssey
When you are standing at the edge of science, especially with a child experiencing seizures, you mobilize every rend world experts willing to push the boundaries to find answers. Our responsibility is to ensure those families have the support, access, and innovation needed to find answers and improved health outcomes. We must end the diagnostic odyssey
